Stock of the Day for November 6, 2024

McKesson Stock Report

McKesson
MCK 90-day performance NYSE:MCK McKesson
Current Price
$947.39
+10.25 (+1.09%)
(As of 02/20/2026 03:59 PM ET)
30 Day Performance
15.58%
  
 
90 Day Performance
8.97%
  
 
1 Year Performance
58.51%
  
 
Market Capitalization
$116.05B
P/E Ratio
27.25
Dividend Yield
0.35%

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers. McKesson also offers a range of technology and automation solutions — including pharmacy automation, supply chain management software, and analytics — designed to improve operational efficiency, inventory control and patient safety for its customers. In addition, the firm provides support services such as clinical program management, patient access and adherence services for specialty therapies, and commercial services for biopharma manufacturers.

McKesson serves a broad customer base that includes retail and independent pharmacies, long-term care providers, hospitals and health systems, physician offices and specialty clinics. While its operations are concentrated in the United States and Canada, the company works with global pharmaceutical manufacturers and participates in international supply chain activities. Its business model emphasizes integration between distribution, technology and services to support the delivery of medications and related care.

Led by a corporate management team focused on resilience and technology-enabled solutions, McKesson has leveraged its long history in healthcare distribution to prioritize supply chain reliability, digital transformation and expanded services for specialty and complex therapies. The company’s combination of logistics capabilities, service offerings and health-technology products positions it as a key intermediary in the U.S. healthcare system.

MCK Company Calendar

DEC. 1, 2025
Ex-Dividend for 1/2 Dividend
JAN. 2, 2026
Dividend Payable
FEB. 4, 2026
Last Earnings
FEB. 22, 2026
Today
MAR. 2, 2026
Ex-Dividend for 4/1 Dividend
MAR. 31, 2026
Fiscal Year End
APR. 1, 2026
Dividend Payable

Recent McKesson News

Tredje AP fonden Raises Stock Holdings in McKesson Corporation $MCK
STAA Gains FDA Nod to Expand EVO ICL Age Indication to 60 Years
3 Market-Beating Stocks for Long-Term Investors
AMN Q4 Earnings Meet Estimates, Revenues Beat, Gross Margin Contracts
Jupiter Asset Management Ltd. Purchases New Stake in McKesson Corporation $MCK
Cumberland Partners Ltd Trims Stock Position in McKesson Corporation $MCK
CenterBook Partners LP Trims Position in McKesson Corporation $MCK
This report was written by MarketBeat.com on February 22, 2026. This report first appeared on MarketBeat.com.